While investors reacted surprisingly negatively to BioNTech’s quarterly numbers and 2022 growth forecast in the US stock market yesterday, the tide turned during the day. Shares of BioNTech rose from $150.25 to $161.5 during trading on the NASDAQ. It finally settled at $160.72, just off the day’s high — after all, the biotech stock was up more than percent the day before. With the increase, the stock price of BioNTech managed to extend the upward trend of the last few days. Down from $118.31 in October. 20 to yesterday’s peak. The technically strong and important support area at $117/121 strengthened again. With the rally, shares of BioNTech are now targeting the 200-day moving average. The EMA 200 as a key resistance for BioNTech shares is the moving average, currently at $160.93, slowly starting to decline. A break above this in such a situation could be seen as a technical buy signal for BioNTech stock (WKN: A2PSR2, ISIN: US09075V1026, chart). Next resistance levels for the biotech stock would then be around $169.95 / $172.75 and the $170.93 / $177.63.